Gyre Therapeutics, Inc. (GYRE)
NASDAQ: GYRE · Real-Time Price · USD
6.71
-0.16 (-2.33%)
At close: Oct 13, 2026, 4:00 PM EDT
6.80
+0.09 (1.34%)
After-hours: Oct 13, 2026, 7:56 PM EDT
Gyre Therapeutics Market Cap
Gyre Therapeutics has a market cap or net worth of $711.49 million as of October 13, 2026. It is the 12,407th most valuable company in the world and the 2,489th biggest in the United States. Its market cap has decreased by 1.59% in one year.
Market Cap
711.49M
Enterprise Value
640.11M
1-Year Change
-1.59%
Global Rank
Country Rank
#2,489 United States
Category
ChartMarket Cap Chart
Since October 31, 2023, Gyre Therapeutics's market cap has increased from $515.41M to $711.49M, an increase of 38.04%. That is a compound annual growth rate of 11.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 711.49M | 10.88% |
| Dec 31, 2025 | 641.69M | -38.21% |
| Dec 31, 2024 | 1.04B | -47.22% |
| Dec 29, 2023 | 1.97B | 281.72% |
| Oct 31, 2023 | 515.41M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Obsidian Therapeutics | 742.51M |
| Apnimed | 734.37M |
| Lexicon Pharmaceuticals | 727.50M |
| Annexon | 726.09M |
| Immix Biopharma | 724.57M |
| Achieve Life Sciences | 722.38M |
| Sana Biotechnology | 718.47M |
| Candel Therapeutics | 713.15M |